No title
In 2020, breast cancer became the most common type of cancer worldwide. While treatment and technology have radically improved, leading to high 5-year survival, the long-term survival of breast cancer is still poor. Gene expression profiling of patients is an important source of information for outcome prediction. The Sweden Cancerome Analysis Network-Breast (SCAN-B) was initiated in 2009 and prov
